NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/14/2017
Back to search
Official data from USPTO
MELIOR PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MELIOR PHARMACEUTICALS
ST13
US500000078946872Class
42
Filing
78946872
Registration
3410932
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
06/14/2017
Trademark type
Word
Nice classes
42
Filing date
08/07/2006
Registration date
04/08/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2017
Last transaction
06/14/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/03/2007
First use in commerce
02/03/2007
Drawing code
4
Owner type
03
Owner location
Exton, PA
Examiner
PEREZ, STEVEN M
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Melior Discovery, Inc.
Representatives
Leslie H Smith LIACOURAS & SMITH, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development of pharmaceutical preparations; pharmaceutical research servicesdeveloping new uses for pharmaceutical compounds through the use of animal models; contract research services in support of scientific research and development of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/14/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/14/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/14/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
04/25/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/08/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/10/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/10/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/10/2013
E815
TEAS SECTION 8 & 15 RECEIVED
04/19/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
03/04/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/27/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/22/2008
IUAF
USE AMENDMENT FILED
12/20/2007
EISU
TEAS STATEMENT OF USE RECEIVED
12/20/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/03/2007
PUBO
PUBLISHED FOR OPPOSITION
04/10/2007
NPUB
NOTICE OF PUBLICATION
03/21/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/22/2007
ALIE
ASSIGNED TO LIE
02/22/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2007
GNRT
NON-FINAL ACTION E-MAILED
01/07/2007
CNRT
NON-FINAL ACTION WRITTEN
01/07/2007
DOCK
ASSIGNED TO EXAMINER
12/30/2006
NWAP
NEW APPLICATION ENTERED
08/11/2006
Continuous trademark protection
Get notified about every new filing that threatens MELIOR PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.